Federal IDR outcomes: Obstetrics and gynecology in Texas
In 2025 Q1–Q4, the provider or facility offer prevailed in 98.5% of 549 determined Federal IDR dispute line items for obstetrics and gynecology in Texas. The median prevailing offer was 56.85x the QPA (25th–75th percentile 12.84x–146.93x; n = 492). The median time to a decision was 39 business days (n = 549).
Determined line items
549
2025 Q1–Q4 · 0 split decisions excluded
Provider win rate
98.5%
n = 549 · 2025 Q1–Q4
Median days to decision
39
business days, from dispute initiation · n = 549 · 2025 Q1–Q4
Dollar amounts are not shown for specialty groups: the CMS QPA and Offers file, the only source of dollar figures, has no specialty field. See methodology.
By period
| Period | Line items | Win % | Median ×QPA | 25th–75th | Ratio n | Median days |
|---|---|---|---|---|---|---|
| 2025 Q1–Q4 | 549 | 98.5% | 56.85x † | 12.84x–146.93x | 492 | 39 |
| 2024 Q1–Q4 | 213 | 93.4% | 52.48x † | 14.08x–146.17x | 192 | 32 |
| 2023 Q1–Q4 | Fewer than 30 determined line items; not shown. | |||||
| 2023 Q1–2025 Q4 | 772 | 97.0% | 57.02x † | 12.89x–145.48x | 694 | not pooled |
Line items = determined dispute line items (n). Win rate excludes split decisions and includes default decisions. Ratio n = line items reporting a payment-to-QPA ratio. Days are business days as reported by CMS (2023–2024: from IDR entity assignment; 2025: from initiation) and are never pooled.
Most disputed CPT codes
| CPT code | Line items | Win % | Median ×QPA | Ratio n | Median days |
|---|---|---|---|---|---|
| 50949 Other procedure on ureter using an endoscope | 74 | 100.0% | 54.26x † | 62 | 42 |
| 64999 Other procedure on nervous system | 74 | 97.3% | 269.37x † | 67 | 42 |
| 45499 Other procedure on rectum using an endoscope | 73 | 98.6% | 37.22x † | 63 | 41 |
| 58662 Destruction or removal of ovary or growth of pelvis using an endoscope | 70 | 100.0% | 49.29x † | 67 | 36.5 |
| 51999 Other procedure on bladder using an endoscope | 43 | 100.0% | 32.45x † | 39 | 36 |
| 58999 Other procedure on female genital system (nonobstetrical) | 40 | 100.0% | 109.20x † | 34 | 38.5 |
| 58558 Biopsy of lining of uterus and/or removal of polyp using an endoscope | 30 | 100.0% | 82.41x † | 30 | 39.5 |
2025 Q1–Q4 · rows with n ≥ 30 determined line items · sorted by n.
Related: all specialties in Texas · Obstetrics and gynecology in all states
FAQ
What is the Federal IDR provider win rate for obstetrics and gynecology in Texas?
In 2025 Q1–Q4, the provider or facility offer was selected in 98.5% of 549 determined dispute line items for obstetrics and gynecology in Texas. Split decisions are excluded from the denominator and default decisions are included. Withdrawn, settled and ineligible disputes are not in the CMS data.
How do Federal IDR payments compare with the QPA for obstetrics and gynecology in Texas?
In 2025 Q1–Q4, the median prevailing offer was 56.85x the qualifying payment amount (QPA), with a 25th to 75th percentile range of 12.84x to 146.93x (n = 492 line items). This uses the CMS field Prevailing Party Offer as % of QPA, where 1.00x equals the QPA.
How long do Federal IDR decisions take for obstetrics and gynecology in Texas?
In 2025 Q1–Q4, the median was 39 business days (n = 549 line items), using the CMS field Length of Time to Make Determination (from dispute initiation).